Your browser doesn't support javascript.
loading
Severe acute respiratory syndrome coronavirus 2 and respiratory syncytial virus coinfection in children.
Zandi, Milad; Soltani, Saber; Fani, Mona; Abbasi, Samaneh; Ebrahimi, Saeedeh; Ramezani, Ali.
Afiliação
  • Zandi M; Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  • Soltani S; Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran.
  • Fani M; Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  • Abbasi S; Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran.
  • Ebrahimi S; Department of Pathobiology and Laboratory Sciences, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran.
  • Ramezani A; Department of Microbiology, School of Medicine, Abadan University of Medical Sciences, Abadan, Iran.
Osong Public Health Res Perspect ; 12(5): 286-292, 2021 Oct.
Article em En | MEDLINE | ID: mdl-34719220
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has infected many people around the world. Children are considered an important target group for SARS-CoV-2, as well as other viral infections such as respiratory syncytial virus infection. Both SARS-CoV-2 and respiratory syncytial virus can affect the respiratory tract. Coinfection of SARS-CoV-2 and respiratory syncytial virus can pose significant challenges in terms of diagnosis and treatment in children. This review compares the symptoms, diagnostic methods, and treatment of COVID-19 and respiratory syncytial virus infection in children.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article